MX2020010113A - Composicion farmaceutica que comprende brexpiprazol. - Google Patents
Composicion farmaceutica que comprende brexpiprazol.Info
- Publication number
- MX2020010113A MX2020010113A MX2020010113A MX2020010113A MX2020010113A MX 2020010113 A MX2020010113 A MX 2020010113A MX 2020010113 A MX2020010113 A MX 2020010113A MX 2020010113 A MX2020010113 A MX 2020010113A MX 2020010113 A MX2020010113 A MX 2020010113A
- Authority
- MX
- Mexico
- Prior art keywords
- pharmaceutical composition
- brexpiprazole
- granulate
- relates
- present
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 5
- ZKIAIYBUSXZPLP-UHFFFAOYSA-N brexpiprazole Chemical compound C1=C2NC(=O)C=CC2=CC=C1OCCCCN(CC1)CCN1C1=CC=CC2=C1C=CS2 ZKIAIYBUSXZPLP-UHFFFAOYSA-N 0.000 title abstract 4
- 229960001210 brexpiprazole Drugs 0.000 title abstract 4
- 239000008187 granular material Substances 0.000 abstract 3
- 239000002552 dosage form Substances 0.000 abstract 1
- 238000005469 granulation Methods 0.000 abstract 1
- 230000003179 granulation Effects 0.000 abstract 1
- 239000007788 liquid Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
- 238000005550 wet granulation Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1611—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
- A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
Landscapes
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La presente invención se relaciona con una composición farmacéutica que comprende un granulado que comprende brexpiprazol, en donde el granulado se obtiene mediante granulación húmeda de un vehículo usando un líquido de granulación que es una solución de brexpiprazol en un sistema disolvente; la presente invención se relaciona también con un granulado utilizado en la composición farmacéutica y con una forma de dosificación unitaria que comprende la composición farmacéutica y con el método para fabricar una composición farmacéutica que comprende brexpiprazol.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP18461541.7A EP3545950A1 (en) | 2018-03-26 | 2018-03-26 | Pharmaceutical composition comprising brexpiprazole |
PCT/EP2019/057016 WO2019185432A1 (en) | 2018-03-26 | 2019-03-21 | Pharmaceutical composition comprising brexpiprazole |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2020010113A true MX2020010113A (es) | 2020-11-06 |
Family
ID=61768247
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2020010113A MX2020010113A (es) | 2018-03-26 | 2019-03-21 | Composicion farmaceutica que comprende brexpiprazol. |
Country Status (13)
Country | Link |
---|---|
EP (2) | EP3545950A1 (es) |
KR (1) | KR20200136399A (es) |
AU (1) | AU2019245827B2 (es) |
BR (1) | BR112020019410A2 (es) |
CA (1) | CA3092948A1 (es) |
CO (1) | CO2020012962A2 (es) |
EA (1) | EA202092062A1 (es) |
MX (1) | MX2020010113A (es) |
PH (1) | PH12020551434A1 (es) |
SG (1) | SG11202008768VA (es) |
UA (1) | UA126702C2 (es) |
WO (1) | WO2019185432A1 (es) |
ZA (1) | ZA202006541B (es) |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI320783B (en) | 2005-04-14 | 2010-02-21 | Otsuka Pharma Co Ltd | Heterocyclic compound |
GB2505860B (en) * | 2011-06-27 | 2018-10-31 | Shanghai Zhongxi Pharmaceutical Corp | Aripiprazole medicament formulation and preparation method therefor |
JO3753B1 (ar) | 2011-10-14 | 2021-01-31 | Otsuka Pharma Co Ltd | قرص يتألف من 7-[4-(4-بينزو[بي]ثيوفين-4-ايل-ببرازين-1-1ايل)بوتكسيل]-1اتش-كوينولين-2-وان أو ملح منه |
TW201332572A (zh) | 2011-12-28 | 2013-08-16 | Otsuka Pharma Co Ltd | 具有經取代的β-環糊精之藥物製劑 |
CN105412036A (zh) * | 2015-12-24 | 2016-03-23 | 北京康立生医药技术开发有限公司 | 依匹哌唑口腔崩解片 |
-
2018
- 2018-03-26 EP EP18461541.7A patent/EP3545950A1/en not_active Withdrawn
-
2019
- 2019-03-21 CA CA3092948A patent/CA3092948A1/en active Pending
- 2019-03-21 BR BR112020019410-7A patent/BR112020019410A2/pt unknown
- 2019-03-21 KR KR1020207027317A patent/KR20200136399A/ko not_active Application Discontinuation
- 2019-03-21 MX MX2020010113A patent/MX2020010113A/es unknown
- 2019-03-21 EA EA202092062A patent/EA202092062A1/ru unknown
- 2019-03-21 AU AU2019245827A patent/AU2019245827B2/en active Active
- 2019-03-21 SG SG11202008768VA patent/SG11202008768VA/en unknown
- 2019-03-21 UA UAA202006316A patent/UA126702C2/uk unknown
- 2019-03-21 EP EP19713738.3A patent/EP3773508A1/en active Pending
- 2019-03-21 WO PCT/EP2019/057016 patent/WO2019185432A1/en unknown
-
2020
- 2020-09-10 PH PH12020551434A patent/PH12020551434A1/en unknown
- 2020-10-16 CO CONC2020/0012962A patent/CO2020012962A2/es unknown
- 2020-10-21 ZA ZA2020/06541A patent/ZA202006541B/en unknown
Also Published As
Publication number | Publication date |
---|---|
ZA202006541B (en) | 2021-09-29 |
EP3773508A1 (en) | 2021-02-17 |
EP3545950A1 (en) | 2019-10-02 |
UA126702C2 (uk) | 2023-01-11 |
CA3092948A1 (en) | 2019-10-03 |
AU2019245827B2 (en) | 2024-05-02 |
BR112020019410A2 (pt) | 2021-01-05 |
CO2020012962A2 (es) | 2020-10-30 |
EA202092062A1 (ru) | 2020-11-03 |
WO2019185432A1 (en) | 2019-10-03 |
PH12020551434A1 (en) | 2021-09-01 |
SG11202008768VA (en) | 2020-10-29 |
AU2019245827A1 (en) | 2020-09-24 |
KR20200136399A (ko) | 2020-12-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MY196909A (en) | Boronic acid derivatives and therapeutic uses thereof | |
PH12017502315B1 (en) | New bicyclic derivatives, a process for their preparation and pharmaceutical compositions containing them | |
JO3675B1 (ar) | مشتقات هيدروكسي إستر جديدة،عملية لتحضيرها وتركيبات صيدلية تحتوي عليها | |
MX2017010858A (es) | Composicion para el tratamiento de enfermedades relacionadas con la interleucina 6. | |
SA517390586B1 (ar) | مشتقات حمض هيدروكسي جديدة، عملية لتحضيرها وتركيبات صيدلية تحتوي عليها | |
EA201892838A1 (ru) | Новые пиперидинильные производные, способ их получения и фармацевтические композиции, содержащие их | |
GEP201706686B (en) | Novel pyrrole compounds, preparation method thereof, and pharmaceutical compositions containing them | |
GEP201706704B (en) | New phosphate compounds, process for their preparation and pharmaceutical compositions containing them | |
MX2019015744A (es) | Composiciones farmaceuticas. | |
EA201691322A1 (ru) | Фармацевтическая композиция ингибитора dpp-iv в комбинации с метформином | |
MX2016000794A (es) | Composiciones farmaceuticas de pancreatina de potencia alta. | |
EA201790949A1 (ru) | Замещенные 2,4-диаминохинолины в качестве новых противораковых средств | |
MX2020013162A (es) | Comprimidos de liberacion inmediata que contienen un farmaco y procesos para formar los comprimidos. | |
EA202090508A1 (ru) | Изготовление фармацевтических составов | |
EA032927B1 (ru) | Производные гидроксиалкилпиперазина в качестве модуляторов cxcr3 рецептора | |
EA201890419A1 (ru) | ОТСЕЛЕКТИРОВАННЫЙ АМИД γ-ГИДРОКСИМАСЛЯНОЙ КИСЛОТЫ И ЕГО ПРИМЕНЕНИЯ ПРИ ЛЕЧЕНИИ ЗЛОУПОТРЕБЛЕНИЯ АЛКОГОЛЕМ | |
EA201691741A1 (ru) | Фармацевтическая композиция | |
EA202090913A1 (ru) | Композиция таблеток с модифицированным высвобождением, содержащая мирабегрон | |
PH12020551434A1 (en) | Pharmaceutical composition comprising brexpiprazole | |
PH12017500323A1 (en) | P38 map kinase inhibiting indanyl urea compounds | |
EA201600400A1 (ru) | Противоопухолевая фармацевтическая композиция, содержащая темозоломид, и способ ее получения | |
MX2020011170A (es) | Derivados de 1-imidazotiadiazol-2h-pirrol-5-ona. | |
PH12019500992A1 (en) | Directly tablettable matrix for producing tablets with extended active substance delivery | |
MX2018002786A (es) | Composicion farmaceutica de vinpocetina. | |
GR1008366B (el) | Διεργασια παραγωγης ταχεως αποσαθρουμενων αναβραζοντων σφαιριδιων, κοκκιων ή/και μειγματων τους |